レナサイエンスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/10/07 | 2,034 | 2,034 | 2,034 | 2,034 | +400 | +24.5% | 26,900 |
| 2025/10/06 | 1,677 | 1,677 | 1,611 | 1,634 | +26 | +1.6% | 284,900 |
| 2025/10/03 | 1,599 | 1,631 | 1,572 | 1,608 | -12 | -0.7% | 347,400 |
| 2025/10/02 | 1,575 | 1,649 | 1,502 | 1,620 | +43 | +2.7% | 1,232,700 |
| 2025/10/01 | 1,671 | 1,765 | 1,560 | 1,577 | -119 | -7% | 982,000 |
| 2025/09/30 | 1,630 | 1,731 | 1,610 | 1,696 | +55 | +3.4% | 651,700 |
| 2025/09/29 | 1,732 | 1,765 | 1,610 | 1,641 | -163 | -9% | 1,048,300 |
| 2025/09/26 | 1,780 | 1,921 | 1,738 | 1,804 | +175 | +10.7% | 3,449,000 |
| 2025/09/25 | 2,122 | 2,122 | 1,629 | 1,629 | -500 | -23.5% | 1,160,900 |
| 2025/09/24 | 2,050 | 2,170 | 2,003 | 2,129 | +93 | +4.6% | 484,700 |
| 2025/09/22 | 2,039 | 2,079 | 2,003 | 2,036 | +22 | +1.1% | 271,500 |
| 2025/09/19 | 1,970 | 2,059 | 1,962 | 2,014 | +69 | +3.5% | 506,400 |
| 2025/09/18 | 1,963 | 1,983 | 1,905 | 1,945 | -7 | -0.4% | 227,500 |
| 2025/09/17 | 1,915 | 1,980 | 1,905 | 1,952 | +18 | +0.9% | 184,100 |
| 2025/09/16 | 1,923 | 1,960 | 1,900 | 1,934 | +14 | +0.7% | 210,600 |
| 2025/09/12 | 1,969 | 1,970 | 1,886 | 1,920 | -34 | -1.7% | 296,200 |
| 2025/09/11 | 1,989 | 2,000 | 1,928 | 1,954 | +28 | +1.5% | 323,000 |
| 2025/09/10 | 1,924 | 1,934 | 1,862 | 1,926 | +3 | +0.2% | 348,300 |
| 2025/09/09 | 1,976 | 1,997 | 1,900 | 1,923 | -42 | -2.1% | 312,200 |
| 2025/09/08 | 1,990 | 2,010 | 1,958 | 1,965 | -34 | -1.7% | 275,700 |
| 2025/09/05 | 1,972 | 2,010 | 1,925 | 1,999 | -21 | -1% | 713,900 |
| 2025/09/04 | 2,121 | 2,147 | 2,010 | 2,020 | -116 | -5.4% | 575,000 |
| 2025/09/03 | 2,113 | 2,156 | 2,071 | 2,136 | -11 | -0.5% | 319,300 |
| 2025/09/02 | 2,118 | 2,174 | 2,091 | 2,147 | +49 | +2.3% | 296,500 |
| 2025/09/01 | 2,105 | 2,152 | 2,041 | 2,098 | -57 | -2.6% | 440,500 |
| 2025/08/29 | 2,237 | 2,268 | 2,135 | 2,155 | -56 | -2.5% | 608,600 |
| 2025/08/28 | 2,171 | 2,245 | 2,111 | 2,211 | ±0 | ±0% | 620,300 |
| 2025/08/27 | 2,120 | 2,218 | 2,085 | 2,211 | +111 | +5.3% | 637,900 |
| 2025/08/26 | 2,196 | 2,201 | 2,076 | 2,100 | -80 | -3.7% | 664,800 |
| 2025/08/25 | 2,271 | 2,291 | 2,008 | 2,180 | -110 | -4.8% | 1,797,700 |
| 2025/08/22 | 2,454 | 2,490 | 2,285 | 2,290 | -160 | -6.5% | 1,044,800 |
| 2025/08/21 | 2,569 | 2,603 | 2,450 | 2,450 | -91 | -3.6% | 668,300 |
| 2025/08/20 | 2,525 | 2,580 | 2,494 | 2,541 | -1 | ±0% | 451,100 |
| 2025/08/19 | 2,718 | 2,760 | 2,530 | 2,542 | -178 | -6.5% | 1,244,900 |
| 2025/08/18 | 2,603 | 2,756 | 2,600 | 2,720 | +80 | +3% | 666,600 |
| 2025/08/15 | 2,821 | 2,840 | 2,580 | 2,640 | -229 | -8% | 1,790,900 |
| 2025/08/14 | 3,090 | 3,160 | 2,832 | 2,869 | -123 | -4.1% | 1,749,700 |
| 2025/08/13 | 3,100 | 3,170 | 2,985 | 2,992 | -128 | -4.1% | 708,000 |
| 2025/08/12 | 3,085 | 3,140 | 3,035 | 3,120 | +35 | +1.1% | 406,900 |
| 2025/08/08 | 3,070 | 3,155 | 3,005 | 3,085 | +20 | +0.7% | 743,000 |
| 2025/08/07 | 2,990 | 3,065 | 2,958 | 3,065 | +50 | +1.7% | 889,900 |
| 2025/08/06 | 2,785 | 3,040 | 2,757 | 3,015 | +230 | +8.3% | 2,380,500 |
| 2025/08/05 | 2,943 | 2,951 | 2,782 | 2,785 | -118 | -4.1% | 1,040,200 |
| 2025/08/04 | 2,930 | 3,030 | 2,900 | 2,903 | -73 | -2.5% | 921,500 |
| 2025/08/01 | 3,025 | 3,110 | 2,961 | 2,976 | -94 | -3.1% | 860,200 |
| 2025/07/31 | 3,155 | 3,310 | 3,050 | 3,070 | -70 | -2.2% | 1,015,300 |
| 2025/07/30 | 3,020 | 3,160 | 2,978 | 3,140 | +100 | +3.3% | 925,100 |
| 2025/07/29 | 2,970 | 3,065 | 2,858 | 3,040 | +30 | +1% | 972,800 |
| 2025/07/28 | 2,961 | 3,040 | 2,910 | 3,010 | +40 | +1.3% | 832,500 |
| 2025/07/25 | 3,070 | 3,090 | 2,960 | 2,970 | -90 | -2.9% | 1,003,600 |
1～
50
件表示中 / 989件
類似銘柄と比較する
現在ご覧いただいている「レナサイエンス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| レナサイエンス | 203,400円 | -14.4% | - | 0.00% | - | 15.04倍 |
|
東北大発創薬ベンチャー。創業者の宮田同大教授が発見した低分子化合物を使い治療薬を開発 |
| アンジェス | 9,000円 | +110.0% | - | 0.00% | - | 10.46倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
| ミズホメディ | 166,400円 | -20.7% | -41.2% | 5.71% | 14.18倍 | 1.84倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| ＣＡＮＢＡＳ | 106,100円 | - | - | 0.00% | - | 7.18倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| 扶桑薬 | 217,000円 | +1.6% | -12.7% | 4.15% | 8.06倍 | 0.56倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
市場注目の銘柄
チャート関連のコラム
